The AI Drug Repurposing Trick Solo Builders Should Steal Right Now
🎧 Prefer to listen? Your browser does not support the audio element. Miles Wang just left OpenAI to build a $2 billion startup. His strategy? Not inventing new drugs — finding new uses for drugs that already exist. Compounds that passed safety testing but failed for their original purpose. The hard part (proving they’re safe) is already done. He just has to figure out what else they can treat. ...